Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 20 | $4.37 | $5.23 | $4.77 |
| Q2 2026 | 18 | $5.45 | $5.86 | $5.62 |
| Q3 2026 | 18 | $5.57 | $6.14 | $5.79 |
| Q4 2026 | 17 | $5.28 | $6.14 | $5.80 |
| Q1 2027 | 7 | $5.41 | $5.76 | $5.59 |
| Q2 2027 | 15 | $6.06 | $6.45 | $6.27 |
| Q3 2027 | 9 | $5.94 | $6.32 | $6.14 |
| Q4 2027 | 7 | $6.14 | $6.54 | $6.35 |
| Q1 2028 | 9 | $5.64 | $6.01 | $5.83 |
| Q2 2028 | 8 | $6.39 | $6.80 | $6.60 |
| Q3 2028 | 14 | $6.24 | $6.64 | $6.44 |
| Q4 2028 | 8 | $6.13 | $6.53 | $6.34 |
AMGEN Inc. last posted its earnings results on Tuesday, August 4th, 2026. The company reported $6.29 earnings per share for the quarter, topping analysts' consensus estimates of $5.62 by $0.67. The company had revenue of 10.05 B for the quarter and had revenue of 36.74 B for the year. AMGEN Inc. has generated $14 earnings per share over the last year ($14.23 diluted earnings per share) and currently has a price-to-earnings ratio of 27.09. AMGEN Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/04/2026 | Q2 2026 | N/A | $4.40 | N/A | $9.43 B | $10.05 B |
| 04/30/2026 | Q1 2026 | $4.77 | $3.37 | -1.4 | $8.58 B | $8.62 B |
| 02/13/2026 | Q4 2025 | N/A | $2.47 | N/A | $9.47 B | $9.90 B |
| 11/04/2025 | Q3 2025 | N/A | $5.98 | N/A | $8.97 B | $9.56 B |
| 08/05/2025 | Q2 2025 | N/A | $2.66 | N/A | $8.94 B | $9.17 B |
| 05/01/2025 | Q1 2025 | N/A | $3.22 | N/A | $8.06 B | $8.15 B |
| 02/14/2025 | Q4 2024 | N/A | $1.17 | N/A | $8.88 B | $9.09 B |
| 10/30/2024 | Q3 2024 | N/A | $5.27 | N/A | $8.50 B | $8.50 B |
| 08/06/2024 | Q2 2024 | N/A | $1.39 | N/A | $8.35 B | $8.39 B |
| 05/02/2024 | Q1 2024 | N/A | -$0.21 | N/A | $7.45 B | $7.45 B |
| 02/14/2024 | Q4 2023 | N/A | $1.43 | N/A | $8.13 B | $8.20 B |
| 10/31/2023 | Q3 2023 | $4.65 | $3.23 | -1.42 | $6.93 B | $6.90 B |
| 08/03/2023 | Q2 2023 | N/A | $2.58 | N/A | $6.66 B | $6.99 B |
| 04/27/2023 | Q1 2023 | N/A | $5.32 | N/A | $6.15 B | $6.11 B |
| 02/09/2023 | Q4 2022 | N/A | $3.02 | N/A | $6.74 B | $6.84 B |
| 11/03/2022 | Q3 2022 | N/A | $4.01 | N/A | $6.56 B | $6.65 B |
| 08/04/2022 | Q2 2022 | N/A | $2.46 | N/A | $6.53 B | $6.59 B |
| 04/27/2022 | Q1 2022 | N/A | $2.69 | N/A | $6.07 B | $6.24 B |
| 02/16/2022 | Q4 2021 | N/A | $3.38 | N/A | $6.87 B | $6.85 B |
| 11/02/2021 | Q3 2021 | N/A | $3.32 | N/A | $6.67 B | $6.71 B |
In the previous quarter, AMGEN Inc. (:AMGN) reported $6.29 earnings per share (EPS) to beat the analysts' consensus estimate of $5.62 by $0.67.
The conference call for AMGEN Inc.'s latest earnings report can be listened to online.
The conference call transcript for AMGEN Inc.'s latest earnings report can be read online.
AMGEN Inc. (:AMGN) has a recorded annual revenue of $36.74 B.
AMGEN Inc. (:AMGN) has a recorded net income of $7.71 B.AMGEN Inc. has generated $14.33 earnings per share over the last four quarters.
AMGEN Inc. (:AMGN) has a price-to-earnings ratio of 27.09 and price/earnings-to-growth ratio is 0.86.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED